AV Node Isolation in Atrial Fibrillation vs. Modulation by "Pace and Ablate" Strategy
NCT ID: NCT04859933
Last Updated: 2022-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2020-10-01
2022-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Line Versus Spot Ablation in Persistent Atrial Fibrillation
NCT00196157
Repeat Ablation Procedure in Patients With Relapse of Atrial Fibrillation
NCT01229306
High Power Short Duration Ablation Compared to Moderate Power Long Duration Ablation for Pulmonary Vein Isolation
NCT05959798
Treatment of Atrial Fibrillation by Minimal Invasive Surgery
NCT00448656
Stepwise Approach Versus Linear Ablation in Patients With Recurrence of Persistent Atrial Fibrillation
NCT01229475
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AVNA group
Group of historical controls beeing treated with AV-node ablation
AV-node ablation
Right sided ablation of the AV-node
AVNI group
Inculudes all patients beeing treated with AV-node isolation
AV-node isolation
Abaltion performed in the right atrium isolating the AV-node from the atrium
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AV-node isolation
Abaltion performed in the right atrium isolating the AV-node from the atrium
AV-node ablation
Right sided ablation of the AV-node
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heart and Diabetes Center North-Rhine Westfalia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum
Bad Oeynhausen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HDZ_ER_003_GI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.